SPERO THERAPEUTICS INC (SPRO)       2.07  +0.05 (+2.48%)

2.07  +0.05 (+2.48%)

US84833T1034 - Common Stock

Buy % Consensus

78
Analysts have set a mean price target of 9.95. This target is 380.43% above the current price.
SPRO was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about SPRO.
In the previous month the buy percentage consensus was at a similar level.
SPRO was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 2.072.026.129.9526.25 - -2.42% 195.65% 380.43% 1,168.12%

Up and Down Grades

Date Firm Action Rating
2022-09-26 HC Wainwright & Co. Maintains Buy
2022-09-23 Evercore ISI Group Upgrade In-Line -> Outperform
2022-08-15 HC Wainwright & Co. Maintains Buy
2022-05-23 HC Wainwright & Co. Maintains Buy
2022-05-20 Berenberg Downgrade Buy -> Hold
2022-05-17 Cantor Fitzgerald Maintains Overweight
2022-05-04 Cowen & Co. Downgrade Outperform -> Market Perform
2022-05-04 Evercore ISI Group Downgrade Outperform -> In-Line
2022-04-18 HC Wainwright & Co. Maintains Buy
2021-10-01 Oppenheimer Downgrade Outperform -> Perform

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA